Multiple sclerosis patients who are stable on interferon therapy show better outcomes when staying on same therapy than patients who switch to another interferon

• Päätekijät: Chen C (Tekijä), Wu N (Tekijä), Watson C (Tekijä)
• Aineistotyyppi: Kirja
• Julkaistu: Dove Medical Press, 2018-11-01T00:00:00Z.
• Aiheet: article
• Linkit: Connect to this object online.

Chao Chen,1 Ning Wu,2 Crystal Watson2 1Pharmaceutical Outcomes and Policy, College of Pharmacy, University of Florida, Gainesville, FL, USA; 2Value and Access, Biogen, Cambridge, MA, USA Background: Real-world outcomes from staying on an interferon beta (IFNβ) vs switching to anoth...